The Human Proteome Organization Chromosome 6 Consortium: Integrating chromosome-centric and biology/disease driven strategies

Journal of Proteomics

Volumn 100, Issue , 2014, Pages 60-67

  Borchers, C H ^a   Kast, J ^b   Foster, L J ^b   Siu, K W M ^c   Overall, C M ^b   Binkowski, T A ^d   Hildebrand, W H ^e   Scherer, A ^f   Mansoor, M ^b   Keown, P A ^b  

^a UNIVERSITY OF VICTORIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c YORK UNIVERSITY   (Canada)

^d ARGONNE NATIONAL LABORATORY   (United States)

^e UNIVERSITY OF OKLAHOMA   (United States)

^f WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Chromosome 6; Human Proteome Project; Proteomics

Indexed keywords

PROTEOME; HLA ANTIGEN; HLA DQ ANTIGEN; LIGAND; MEMBRANE PROTEIN; TRANSCRIPTION FACTOR;

ALZHEIMER DISEASE; CANADA; CHROMOSOME 6; CHROMOSOME MAP; CHROMOSOME STRUCTURE; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIBRARY SCIENCE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; SCHIZOPHRENIA; CHRONIC DISEASE; GENETIC DISEASES, INBORN; GENETICS; GENOMICS; HUMAN GENOME PROJECT; MAJOR HISTOCOMPATIBILITY COMPLEX; METABOLISM; ORGANIZATION AND MANAGEMENT;

CANADA; CHROMOSOMES, HUMAN, PAIR 6; CHRONIC DISEASE; GENETIC DISEASES, INBORN; GENOMICS; HLA ANTIGENS; HLA-DQ BETA-CHAINS; HUMAN GENOME PROJECT; HUMANS; LIGANDS; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMBRANE PROTEINS; PROTEOME; TRANSCRIPTION FACTORS;

EID: 84897055735     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2013.08.001     Document Type: Review

References (54)

1. Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., Wilming L., et al. The DNA sequence and analysis of human chromosome 6. Nature 2003, 425:805-811.
2. Flicek P., Amode M.R., Barrell D., Beal K., Brent S., Carvalho-Silva D., et al. Ensembl 2011. Nucleic Acids Res 2011, 39:D800-D806.
3. Naj A.C., Beecham G.W., Martin E.R., Gallins P.J., Powell E.H., Konidari I., et al. Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities. PLoS Genet 2010, 6:e1001130. 10.1371/journal.pgen.1001130.
4. Concannon P., Rich S.S., Nepom G.T. Genetics of type 1A diabetes. N Engl J Med 2009, 360:1646-1654.
5. Veeriah S., Taylor B.S., Meng S., Fang F., Yilmaz E., Vivanco I., et al. Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat Genet 2010, 42:77-82.
6. Horton R., Wilming L., Rand V., Lovering R.C., Bruford E.A., Khodiyar V.K., et al. Gene map of the extended human MHC. Nat Rev Genet 2004, 5:889-899.
7. Communications LHNCfB: conditions related to genes on chromosome 6. Lister Hill National Center for Biomedical Communications 2012.
8. Wu E.Q., Birnbaum H.G., Shi L., Ball D.E., Kessler R.C., Moulis M., et al. The economic burden of schizophrenia in the United States in 2002. J Clin Psychiatry 2005, 66:1122-1129.
9. AARDA, NCAPG The cost burden of autoimmune disease: the latest front in the war on healthcare spending 2000, American Autoimmune Related Disease Association (AARDA) and the National Coalition of Autoimmune Patient Groups (NCAPG).
10. Lin R.J., Cherry A.M., Chen K.C., Lyons M., Hoyme H.E., Hudgins L. Terminal deletion of 6p results in a recognizable phenotype. Am J Med Genet A 2005, 136:162-168.
11. DeScipio C. The 6p subtelomere deletion syndrome. Am J Med Genet C Semin Med Genet 2007, 145C:377-382.
12. Canadian Diabetes Association The prevalence and costs of diabetes 2009, Canadian Diabetes Association.
13. Poppe A.Y., Wolfson C., Zhu B. Prevalence of multiple sclerosis in Canada: a systematic review. Can J Neurol Sci 2008, 35:593-601.
14. Arthritis Alliance of Canada: the impact of arthritis in Canada, today and over the next 30years http://www.arthritisalliance.ca.
15. Alzheimer's Society of Canada: rising tide: the impact of dementia on Canadian society http://www.alzheimer.ca/docs/RisingTide.
16. Watanabe O., Arimura K., Kitajima I., Osame M., Maruyama I. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet 1996, 347:702.
17. Hatta Y., Yamada Y., Tomonaga M., Miyoshi I., Said J.W., Koeffler H.P. Detailed deletion mapping of the long arm of chromosome 6 in adult T-cell leukemia. Blood 1999, 93:613-616.
18. McEvoy C.R., Morley A.A., Firgaira F.A. Evidence for whole chromosome 6 loss and duplication of the remaining chromosome in acute lymphoblastic leukemia. Genes Chromosomes Cancer 2003, 37:321-325.
19. La Starza R., Aventin A., Matteucci C., Crescenzi B., Romoli S., Testoni N., et al. Genomic gain at 6p21: a new cryptic molecular rearrangement in secondary myelodysplastic syndrome and acute myeloid leukemia. Leukemia 2006, 20:958-964.
20. Huang L., Yu D., Wu C., Zhai K., Jiang G., Cao G., et al. Copy number variation at 6q13 functions as a long-range regulator and is associated with pancreatic cancer risk. Carcinogenesis 2012, 33:94-100.
21. Cozen W., Li D., Best T., Van Den Berg D.J., Gourraud P.A., Cortessis V.K., et al. A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32. Blood 2012, 119:469-475.
22. López-Nieva P., Vaquero C., Fernández-Navarro P., Gonzalez-Sanchez L., Villa-Morales M., Santos J., et al. EPHA7, a new target gene for 6q deletion in T-cell lymphoblastic lymphomas. Carcinogenesis 2012, 33:452-458.
23. Oricchio E., Nanjangud G., Wolfe A.L., Schatz J.H., Mavrakis K.J., Jiang M., et al. The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma. Cell 2011, 147:554-564.
24. Takeuchi S., Koike M., Seriu T., Bartram C.R., Schrappe M., Reiter A., et al. Frequent loss of heterozygosity on the long arm of chromosome 6: identification of two distinct regions of deletion in childhood acute lymphoblastic leukemia. Cancer Res 1998, 58:2618-2623.
25. Stilgenbauer S., Bullinger L., Benner A., Wildenberger K., Bentz M., Dohner K., et al. Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemia. Leukemia 1999, 13:1331-1334.
26. Bosga-Bouwer A.G., Kok K., Booman M., Boven L., van der Vlies P., van den Berg A., et al. Array comparative genomic hybridization reveals a very high frequency of deletions of the long arm of chromosome 6 in testicular lymphoma. Genes Chromosomes Cancer 2006, 45:976-981.
27. Addona T.A., Abbatiello S.E., Schilling B., Skates S.J., Mani D.R., Bunk D.M., et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol 2009, 27:633-641.
28. Keshishian H., Addona T., Burgess M., Mani D.R., Shi X., Kuhn E., et al. Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteomics 2009, 8:2339-2349.
29. DeSouza L.V., Taylor A.M., Li W., Minkoff M.S., Romaschin A.D., Colgan T.J., et al. Multiple reaction monitoring of mTRAQ-labeled peptides enables absolute quantification of endogenous levels of a potential cancer marker in cancerous and normal endometrial tissues. J Proteome Res 2008, 7:3525-3534.
30. Kuzyk M.A., Smith D., Yang J., Cross T.J., Jackson A.M., Hardie D.B., et al. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol Cell Proteomics 2009, 8:1860-1877.
31. Anderson N.L., Anderson N.G., Haines L.R., Hardie D.B., Olafson R.W., Pearson T.W. Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA). J Proteome Res 2004, 3:235-244.
32. Reid J.D., Holmes D.T., Mason D.R., Shah B., Borchers C.H. Towards the development of an immuno MALDI (iMALDI) mass spectrometry assay for the diagnosis of hypertension. J Am Soc Mass Spectrom 2010, 21:1680-1686.
33. Krivov G.G., Shapovalov M.V., Dunbrack J., Roland L. Improved prediction of protein side-chain conformations with SCWRL4. Proteins 2009, 77:778-795.
34. Luo W, Pei J, Zhu Y. A fast protein-ligand docking algorithm based on hydrogen bond matching and surface shape complementarity. J Mol Model 16: 903-913.
35. Kollman P.A., Massova I., Reyes C., Kuhn B., Huo S., Chong L., et al. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res 2000, 33:889-897.
36. Peters B., Bui H.H., Frankild S., Nielson M., Lundegaard C., Kostem E., et al. A community resource benchmarking predictions of peptide binding to MHC-I molecules. PLoS Comput Biol 2006, 2:e65.
37. Hunt D.F., Henderson R.A., Shabanowitz J., Sakaguchi K., Michel H., Sevilir N., et al. Pillars article: characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 1992. 255: 1261-1263. J Immunol 2007, 179:2669-2671.
38. Zarling A.L., Polefrone J.M., Evans A.M., Mikesh L.M., Shabanowitz J., Lewis S.T., et al. Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy. Proc Natl Acad Sci U S A 2006, 103:14889-14894.
39. Hawkins O.E., Vangundy R.S., Eckerd A.M., Bardet W., Buchli R., Weidanz J.A., et al. Identification of breast cancer peptide epitopes presented by HLA-A*0201. J Proteome Res 2008, 7:1445-1457.
40. Bassani-Sternberg M., Barnea E., Beer I., Avivi I., Katz T., Admon A. Soluble plasma HLA peptidome as a potential source for cancer biomarkers. Proc Natl Acad Sci U S A 2010, 107:18769-18776.
41. Yu H., Karunakaran K.P., Kelly I., Shen C., Jiang X., Foster L.J., et al. Immunization with live and dead Chlamydia muridarum induces different levels of protective immunity in a murine genital tract model: correlation with MHC class II peptide presentation and multifunctional Th1 cells. J Immunol 2011, 186:3615-3621.
42. Aebersold R., Goodlett D.R. Mass spectrometry in proteomics. Chem Rev 2001, 101:269-295.
43. Shastri N., Schwab S., Serwold T. Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. Annu Rev Immunol 2002, 20:463-493.
44. Falk K., Rötzschke O., Stevanović S., Jung G., Rammensee H.G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991, 351:290-296.
45. Domanski D., Percy A.J., Yang J., Chambers A.G., Hill J.S., Freue G.V., et al. MRM-based multiplexed quantitation of 67 putative cardiovascular disease biomarkers in human plasma. Proteomics 2012, 12:1222-1243.
46. Domanski D., Smith D.S., Miller C.A., Yang Y., Jackson A.M., Cohen-Freue G., et al. High-flow multiplexed MRM-based analysis of proteins in human plasma without depletion or enrichment. Clin Lab Med 2011, 31:371-384.
47. Percy A.J., Chambers A.G., Yang J., Domanski D., Borchers C.H. Comparison of standard-flow and nano-flow liquid chromatography systems for MRM-based quantitation of putative plasma biomarker proteins. Anal Bioanal Chem 2012, 404:1089-1101.
48. Kleifeld O., Doucet A., auf dem Keller U., Prudova A., Schilling O., Kainthan R.K., et al. Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products. Nat Biotechnol 2010, 28:281-288.
49. Kleifeld O., Doucet A., Prudova A., auf dem Keller U., Gioia M., Kizhakkedathu J.N., et al. Identifying and quantifying proteolytic events and the natural N terminome by terminal amine isotopic labeling of substrates. Nat Protoc 2011, 6:1578-1611.
50. Schilling O., Barré O., Huesgen P.F., Overall C.M. Proteome-wide analysis of protein carboxy termini: C terminomics. Nat Methods 2010, 7:508-511.
51. Lange P.F., Overall C.M. TopFIND, a knowledgebase linking protein termini with function. Nat Meth 2011, 8:703-704.
52. Huesgen P.F., Lange P.F., Ovarall C.M. Ensembles of protein termini are sensitive and specific proteolytic signature biomarkers of disease. J Prot 2013, [in press].
53. Fahlman R.P., Chen W., Overall C.M. Absolute proteomic quantification of the activity state of proteases and proteolytic cleavages using proteolytic signature peptides and isobaric tags. J Prot 2014, 100:79-91.
54. Lange P.F., Huesgen P.F., Overall C.M. Annotating N termini for the Human Proteome Project: N termini differentiate stable processed protein species from degradation remnants in the human erythrocyte proteome. J Prot 2013, [in press].